MX370730B - Formas cristalinas de maltol férrico. - Google Patents
Formas cristalinas de maltol férrico.Info
- Publication number
- MX370730B MX370730B MX2017005413A MX2017005413A MX370730B MX 370730 B MX370730 B MX 370730B MX 2017005413 A MX2017005413 A MX 2017005413A MX 2017005413 A MX2017005413 A MX 2017005413A MX 370730 B MX370730 B MX 370730B
- Authority
- MX
- Mexico
- Prior art keywords
- crystalline forms
- ferric maltol
- maltol
- ferric
- anaemia
- Prior art date
Links
- 229950008006 ferric maltol Drugs 0.000 title abstract 2
- AHPWLYJHTFAWKI-UHFFFAOYSA-K iron(3+);2-methyl-4-oxopyran-3-olate Chemical compound [Fe+3].CC=1OC=CC(=O)C=1[O-].CC=1OC=CC(=O)C=1[O-].CC=1OC=CC(=O)C=1[O-] AHPWLYJHTFAWKI-UHFFFAOYSA-K 0.000 title abstract 2
- 206010022971 Iron Deficiencies Diseases 0.000 abstract 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1419174.6A GB2531742B (en) | 2014-10-28 | 2014-10-28 | Polymorphs of ferric maltol |
| PCT/EP2015/074653 WO2016066555A1 (en) | 2014-10-28 | 2015-10-23 | Crystalline forms of ferric maltol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017005413A MX2017005413A (es) | 2017-10-04 |
| MX370730B true MX370730B (es) | 2019-12-20 |
Family
ID=52103522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017005413A MX370730B (es) | 2014-10-28 | 2015-10-23 | Formas cristalinas de maltol férrico. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9802973B2 (OSRAM) |
| EP (1) | EP3160951B1 (OSRAM) |
| JP (2) | JP6404358B2 (OSRAM) |
| KR (1) | KR102576930B1 (OSRAM) |
| CN (1) | CN107001310B (OSRAM) |
| AU (1) | AU2015340825B2 (OSRAM) |
| CA (1) | CA2944210C (OSRAM) |
| CL (1) | CL2017001030A1 (OSRAM) |
| EA (1) | EA033323B1 (OSRAM) |
| ES (1) | ES2661944T3 (OSRAM) |
| GB (1) | GB2531742B (OSRAM) |
| IL (1) | IL251863A0 (OSRAM) |
| MX (1) | MX370730B (OSRAM) |
| PL (1) | PL3160951T3 (OSRAM) |
| SA (1) | SA517381406B1 (OSRAM) |
| SG (1) | SG11201702639RA (OSRAM) |
| WO (1) | WO2016066555A1 (OSRAM) |
| ZA (1) | ZA201702136B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2531742B (en) | 2014-10-28 | 2016-10-05 | Iron Therapeutics Holdings Ag | Polymorphs of ferric maltol |
| CN112574158B (zh) * | 2020-12-29 | 2022-08-02 | 南京百泽医药科技有限公司 | 一种麦芽酚铁晶型ii及其制备方法 |
| IT202100018578A1 (it) | 2021-07-14 | 2023-01-14 | Indena Spa | Dispersione amorfa di maltolo ferrico e relativo processo di preparazione |
| WO2023047195A1 (en) * | 2021-09-21 | 2023-03-30 | Rk Pharma Inc. | An improved process for the preparation of ferric maltol |
| CN119638662B (zh) * | 2024-12-09 | 2025-11-14 | 金陵药业股份有限公司 | 一种麦芽酚铁-草酸共晶及其制备方法 |
| CN119638661B (zh) * | 2024-12-09 | 2025-11-14 | 金陵药业股份有限公司 | 一种麦芽酚铁-槲皮素共晶及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE37534E1 (en) | 1982-10-22 | 2002-01-29 | Btg International Limited | Pharmaceutical compositions |
| EP0107458B1 (en) * | 1982-10-22 | 1987-07-29 | National Research Development Corporation | Pharmaceutical compositions |
| GB8410290D0 (en) * | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
| GB0211500D0 (en) * | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| GB201101370D0 (en) * | 2011-01-27 | 2011-03-09 | Iron Therapeutics Holdings Ag | Process |
| WO2014165607A2 (en) | 2013-04-02 | 2014-10-09 | Stealth Peptides International, Inc. | Aromatic-cationic peptide formulations, compositions and methods of use |
| GB2531742B (en) | 2014-10-28 | 2016-10-05 | Iron Therapeutics Holdings Ag | Polymorphs of ferric maltol |
-
2014
- 2014-10-28 GB GB1419174.6A patent/GB2531742B/en active Active
-
2015
- 2015-10-23 MX MX2017005413A patent/MX370730B/es active IP Right Grant
- 2015-10-23 KR KR1020167024732A patent/KR102576930B1/ko active Active
- 2015-10-23 EP EP15784705.4A patent/EP3160951B1/en active Active
- 2015-10-23 JP JP2016551318A patent/JP6404358B2/ja active Active
- 2015-10-23 ES ES15784705.4T patent/ES2661944T3/es active Active
- 2015-10-23 EA EA201790667A patent/EA033323B1/ru not_active IP Right Cessation
- 2015-10-23 WO PCT/EP2015/074653 patent/WO2016066555A1/en not_active Ceased
- 2015-10-23 PL PL15784705T patent/PL3160951T3/pl unknown
- 2015-10-23 AU AU2015340825A patent/AU2015340825B2/en active Active
- 2015-10-23 US US15/039,943 patent/US9802973B2/en active Active
- 2015-10-23 CN CN201580052331.2A patent/CN107001310B/zh active Active
- 2015-10-23 SG SG11201702639RA patent/SG11201702639RA/en unknown
- 2015-10-23 CA CA2944210A patent/CA2944210C/en active Active
-
2017
- 2017-03-27 ZA ZA2017/02136A patent/ZA201702136B/en unknown
- 2017-04-23 IL IL251863A patent/IL251863A0/en unknown
- 2017-04-25 SA SA517381406A patent/SA517381406B1/ar unknown
- 2017-04-26 CL CL2017001030A patent/CL2017001030A1/es unknown
-
2018
- 2018-09-11 JP JP2018169541A patent/JP6678711B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB2531742B (en) | 2016-10-05 |
| JP6678711B2 (ja) | 2020-04-08 |
| JP2018197268A (ja) | 2018-12-13 |
| ZA201702136B (en) | 2018-11-28 |
| KR102576930B1 (ko) | 2023-09-12 |
| KR20170071446A (ko) | 2017-06-23 |
| WO2016066555A1 (en) | 2016-05-06 |
| CL2017001030A1 (es) | 2018-01-19 |
| US20170260222A1 (en) | 2017-09-14 |
| GB201419174D0 (en) | 2014-12-10 |
| EA201790667A1 (ru) | 2017-08-31 |
| SA517381406B1 (ar) | 2021-03-15 |
| CA2944210A1 (en) | 2016-05-06 |
| JP2017535510A (ja) | 2017-11-30 |
| IL251863A0 (en) | 2017-06-29 |
| ES2661944T3 (es) | 2018-04-04 |
| CA2944210C (en) | 2017-06-20 |
| EP3160951A1 (en) | 2017-05-03 |
| AU2015340825A1 (en) | 2016-08-25 |
| AU2015340825B2 (en) | 2016-11-24 |
| CN107001310B (zh) | 2020-05-22 |
| MX2017005413A (es) | 2017-10-04 |
| CN107001310A (zh) | 2017-08-01 |
| PL3160951T3 (pl) | 2018-07-31 |
| JP6404358B2 (ja) | 2018-10-10 |
| BR112017008903A2 (pt) | 2017-12-19 |
| GB2531742A (en) | 2016-05-04 |
| EP3160951B1 (en) | 2017-12-06 |
| EA033323B1 (ru) | 2019-09-30 |
| SG11201702639RA (en) | 2017-05-30 |
| US9802973B2 (en) | 2017-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202307128B (en) | Anti-cd38 antibodies for treatment of acute myeloid leukemia | |
| PH12016501763A1 (en) | Multispecific antibodies | |
| PH12015502401A1 (en) | Compositions and methods for enhancing microbial stability | |
| GEP20197009B (en) | 4'-substituted nucleosidederivatives as hiv reverse transcriptase inhibitors | |
| MX2016016143A (es) | Compuestos de [1,2,4]triazol sustituido. | |
| WO2014165090A8 (en) | Compounds for the treatment of tuberculosis | |
| MY187632A (en) | Methods of forming aromatic containing compounds | |
| MX2017005413A (es) | Formas cristalinas de maltol ferrico. | |
| MY172773A (en) | Use of polyesters with inherent flame retardancy in adhesives and sealants | |
| MX2017006026A (es) | Apilimod para uso en el tratamiento de cancer colorrectal. | |
| IN2015DN01688A (OSRAM) | ||
| PH12015502665A1 (en) | Improvements in or relating to organic compounds | |
| MX2015009818A (es) | Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple. | |
| MX2017005249A (es) | Compuestos para usarse en el tratamiento antihelmintico. | |
| MX2017001047A (es) | Compuestos para usar en el tratamiento antihelmintico. | |
| PH12017501071A1 (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
| MX2020013096A (es) | Rutas semi-sinteticas para compuestos organicos. | |
| HUE064273T2 (hu) | Eljárások iszap vízteleníthetõségének fokozására enzimes kezeléssel | |
| PH12019500479A1 (en) | Compositions for treating dementia | |
| AU359152S (en) | Sliding door trolley | |
| HK1226329A1 (en) | Apilimod compositions and methods for using same | |
| HK1254258A1 (zh) | 使用阿吡莫德治疗癌症的方法 | |
| TH1501004360A (th) | วิธีการในการบำบัดภาวะขาดธาตุเหล็กด้วยเฟอร์ริกไพโรฟอสเฟตที่ละลายได้ | |
| HK1242965A1 (en) | Apilimod for use in the treatment of colorectal cancer | |
| UA99705U (ru) | Способ получения 10-хлор-9-антраценальдегиду и его производных |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |